IDEX IDEX Biometrics ASA

VISA Certifies Biometric Payment Card Secured by IDEX Biometrics TrustedBio Solution

VISA Certifies Biometric Payment Card Secured by IDEX Biometrics TrustedBio Solution

Oslo, Norway – 3 November 2021 - IDEX Biometrics ASA today announced that VISA® has fully certified IDEX Biometrics’ TrustedBio® fingerprint authentication solution, as part of IDEMIA’s F.CODE biometric payment card platform.

This certification provides card issuers access to a world-class biometric card platform. According to Nilson Reports, VISA currently has approximately 3.6 billion cards in circulation and is expected to grow that number 18% by 2026. 

The Letter of Approval (LOA) issued by VISA gives assurance to the payment ecosystem that the F.CODE card payment platform, inclusive of the TrustedBio solution, is fully compliant with EMV® interoperability standards and VISA’s highest security and performance standards. The LOA also assures issuers, merchants, and millions of consumers that the card will operate seamlessly across VISA’s global network, addressing the long-awaited demand for increased security through biometric authentication.

IDEX Biometrics’ Chief Executive Officer, Vince Graziani, commented, “Completion of the VISA certification is an important achievement, as it allows for rapid deployment of biometric cards for all the worldwide banks, challenger banks, fintechs, and other card issuers. Fingerprint biometrics is one of the major technology developments for smart cards in recent years and, enabled by our proprietary solution approach, will play a critical role in the future of payments delivering a better, more secure payment experience.”

For further information contact:

Marianne Bøe, Investor Relations

E-mail:

Tel: +47 9180 0186

Brett L Perry, U.S. Investor Relations

E-mail:

Tel: 0

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal authentication for all.  We help people make payments, prove their identity, gain access to information or unlock devices with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit  

TRADEMARK STATEMENT

IDEX, TrustedBio, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.  

EMV, which stands for Europay, Mastercard and Visa, is the trademark of EMVCo, LLC, which administers standards for card-based transaction and authentication standards.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.



EN
03/11/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch